Cargando…

Targeting neuroinflammation in Alzheimer’s disease

Almost 47 million people suffer from dementia worldwide, with an estimated new case diagnosed every 3.2 seconds. Alzheimer’s disease (AD) accounts for approximately 60%–80% of all dementia cases. Given this evidence, it is clear dementia represents one of the greatest global public health challenges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bronzuoli, Maria Rosanna, Iacomino, Aniello, Steardo, Luca, Scuderi, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098782/ https://www.ncbi.nlm.nih.gov/pubmed/27843334 http://dx.doi.org/10.2147/JIR.S86958

Ejemplares similares

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
por: Steardo, Luca, et al.
Publicado: (2015)

Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2019)

Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2018)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
por: Scuderi, Caterina, et al.
Publicado: (2014)

Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
por: Valenza, Marta, et al.
Publicado: (2021)

Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
por: Scuderi, Caterina, et al.
Publicado: (2018)

Neuroglia in the autistic brain: evidence from a preclinical model
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2018)

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease
por: Scuderi, C, et al.
Publicado: (2014)

Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic
por: Steardo, Luca, et al.
Publicado: (2022)

Altered Waste Disposal System in Aging and Alzheimer’s Disease: Focus on Astrocytic Aquaporin-4
por: Valenza, Marta, et al.
Publicado: (2020)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders
por: Valenza, Marta, et al.
Publicado: (2021)

Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017)

Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease
por: Facchinetti, Roberta, et al.
Publicado: (2022)

Neuroinflammation in Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
por: Esposito, Giuseppe, et al.
Publicado: (2011)

Neuroinflammation in Alzheimer’s disease
por: Zhang, Fengjin, et al.
Publicado: (2015)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
por: Trovato Salinaro, Angela, et al.
Publicado: (2018)

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
por: Barczuk, Julia, et al.
Publicado: (2022)

Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications
por: Si, Zi-Zhen, et al.
Publicado: (2022)

Neuroinflammation and Copper in Alzheimer's Disease
por: Choo, Xin Yi, et al.
Publicado: (2013)

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?
por: Dong, Yuan, et al.
Publicado: (2019)

Rodent models of neuroinflammation for Alzheimer’s disease
por: Nazem, Amir, et al.
Publicado: (2015)

Neuroinflammation and fractalkine signaling in Alzheimer’s disease
por: Finneran, Dylan J., et al.
Publicado: (2019)

Can We Treat Neuroinflammation in Alzheimer’s Disease?
por: Sánchez-Sarasúa, Sandra, et al.
Publicado: (2020)

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
por: Scuderi, Caterina, et al.
Publicado: (2012)

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
por: Dhapola, Rishika, et al.
Publicado: (2021)

In vivo molecular imaging of neuroinflammation in Alzheimer's disease
por: Chaney, Aisling, et al.
Publicado: (2018)

In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
por: Tournier, Benjamin B., et al.
Publicado: (2020)

Alzheimer’s disease: natural products as inhibitors of neuroinflammation
por: Olajide, Olumayokun A., et al.
Publicado: (2020)

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
por: Al-Ghraiybah, Nour F., et al.
Publicado: (2022)

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
por: Wang, Minghui, et al.
Publicado: (2023)

Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
por: Andronie-Cioara, Felicia Liana, et al.
Publicado: (2023)

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
por: Sobue, Akira, et al.
Publicado: (2023)

S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells
por: Esposito, Giuseppe, et al.
Publicado: (2008)

Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
por: Yang, Seung-Hoon
Publicado: (2019)

The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease
por: Stock, Amanda J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4d6d59dbjbr4p16slvesgl6a78